Copper-doped semiconductors are designed to photoassist the alkyne-azide cycloaddition catalysis by Cu(I). Upon irradiation, injection of electrons from the semiconductor into copper oxide nanostructures produces the catalytic Cu(I) species. The new catalysts are air- and moisture-tolerant and can be readily recovered after use and reused several times.
The use of particulate titanium dioxide
(TiO2) as an
active sunscreen ingredient has raised concerns about potential risks
from TiO2-mediated free radical formation. To date, remediation
attempts have concentrated on reducing the yield of free radical generation
by TiO2 upon sunlight exposure. The problem with this approach
is that given the band gap in TiO2, production of radical
and the ensuing reactive oxygen species (ROS) is completely normal.
Our strategy is based on a nontoxic, biocompatible shell that neutralizes
the free radicals by scavenging them with natural antioxidants before
they exit the particle. The new lignin@TiO2 composites
preserve the scattering and absorption properties of TiO2 because the particles retain their nanoscale dimensions as preferred
by the cosmetic industry. Although the target properties for photocatalysis
and sun-protection applications are opposite, we argue that exactly
the same knowledge is required to optimize either one.
The second‐generation Grubbs catalyst, RuCl2(H2IMes)(PCy3) (=CHPh) [GII; H2IMes=1,3‐bis(2,4,6‐trimethylphenyl)‐4,5‐dihydroimidazol‐2‐ylidene, Cy=cyclohexyl], is shown to decompose during olefin metathesis to generate Ru nanoparticles (RuNPs). These RuNPs appear to contribute significantly to competing isomerization during metathesis. Larger, partially oxidized RuNPs are also observed in commercial GII, but these exhibit modest isomerization activity. Removal of RuNPs from the precatalyst does not prevent isomerization, because new, more reactive NPs are generated by catalyst decomposition during metathesis.
The ability to drive reactivity using visible light is of importance for many disciplines of chemistry and has significant implications for sustainable chemistry. Identifying photochemically active compounds and understanding photochemical mechanisms is important for the development of useful materials for synthesis and catalysis. Here we report a series of photoactive diphenyltellurophene compounds bearing electron-withdrawing and electron-donating substituents synthesized by alkyne coupling/ring closing or palladium-catalyzed ipso-arylation chemistry. The redox chemistry of these compounds was studied with respect to oxidative addition and photoelimination of bromine, which is of importance for energy storage reactions involving X2. The oxidative addition reaction mechanism was studied using density functional theory, the results of which support a three-step mechanism involving the formation of an initial η(1) association complex, a monobrominated intermediate, and finally the dibrominated product. All of the tellurophene derivatives undergo photoreduction using 430, 447, or 617 nm light depending on the absorption properties of the compound. Compounds bearing electron-withdrawing substituents have the highest photochemical quantum efficiencies in the presence of an alkene trap, with efficiencies of up to 42.4% for a pentafluorophenyl-functionalized tellurophene. The photoelimination reaction was studied in detail through bromine trapping experiments and laser flash photolysis, and a mechanism is proposed. The photoreaction, which occurs by release of bromine radicals, is competitive with intersystem crossing to the triplet state of the brominated species, as evidenced by the formation of singlet oxygen. These findings should be useful for the design of new photochemically active compounds supported by main-group elements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.